US Patent Issued to Amicus Therapeutics on May 12 for "Formulations comprising recombinant acid Alpha-glucosidase" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,952, issued on May 12, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"Formulations comprising recombinant acid Alpha-glucosidase" was invented by Hing Char (East Brunswick, N.J.), Sergey Tesler (Monroe, N.J.), Wendy Sunderland (Doylestown, Pa.), Enrique Dilone (Basking Ridge, N.J.), Russell Gotschall (Doylestown, Pa.) and Hung V. Do (New Hope, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are pharmaceutical formulations comprising a recombinant acid Alpha-glucosidase, wherein the recombinant acid Alpha-glucosidase is expressed in Chinese hamster ovary (CHO) cells and comprises an increased content of N-glycan units bearing on...